165 related articles for article (PubMed ID: 37266846)
1. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
van Schie P; Rijksen BLT; Bot M; Wiersma T; Merckel LG; Brandsma D; Compter A; de Witt Hamer PC; Post R; Borst GR
J Neurooncol; 2023 Jun; 163(2):345-354. PubMed ID: 37266846
[TBL] [Abstract][Full Text] [Related]
2. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
4. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer.
Noel G; Medioni J; Valery CA; Boisserie G; Simon JM; Cornu P; Hasboun D; Ledu D; Tep B; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Lung Cancer; 2003 Sep; 41(3):333-43. PubMed ID: 12928124
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
8. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors.
Sheehan J; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2005 Jan; 102 Suppl():247-54. PubMed ID: 15662819
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
[TBL] [Abstract][Full Text] [Related]
10. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
11. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
[TBL] [Abstract][Full Text] [Related]
12. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
13. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.
Rava P; Leonard K; Sioshansi S; Curran B; Wazer DE; Cosgrove GR; Norén G; Hepel JT
J Neurosurg; 2013 Aug; 119(2):457-62. PubMed ID: 23662828
[TBL] [Abstract][Full Text] [Related]
14. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
Johung KL; Yeh N; Desai NB; Williams TM; Lautenschlaeger T; Arvold ND; Ning MS; Attia A; Lovly CM; Goldberg S; Beal K; Yu JB; Kavanagh BD; Chiang VL; Camidge DR; Contessa JN
J Clin Oncol; 2016 Jan; 34(2):123-9. PubMed ID: 26438117
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
17. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
19. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
20. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]